What this means
Researchers reviewed 20 studies on GHK-Cu, a copper peptide, for skin and beauty uses. Most were lab or animal studies, and only two were human trials, so more strong testing is still needed.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- 20 studies: 18 lab or animal studies and 2 human trials
- Kind of research
- A study
The science
- Original title
- The Regenerative Potential of GHK-Cu in Aesthetic Medicine.
- Authors
- Mokhtar J, Mohamad B, Haddad J et al.
- Journal
- Aesthetic surgery journal
- Published
- Aug 20, 2026
- Study type
- Study
- PMID
- 42619529 ↗
Abstract
The age-related decline in tissue regenerative capacity drives demand for interventions restoring physiological repair mechanisms. Glycyl-L-histidyl-L-lysine-copper (GHK-Cu) has demonstrated significant regenerative, anti-inflammatory, and antioxidant properties in preclinical models, prompting its increasing integration into aesthetic practice despite a paucity of standardized clinical guidelines. This systematic review evaluates the efficacy, safety, and regenerative mechanisms of GHK-Cu in aesthetic medicine to clarify its clinical utility and inform future research. A systematic search of PubMed, Embase, and Cochrane CENTRAL was conducted from database inception through March 2026, following PRISMA guidelines. Eligible studies included clinical and preclinical models investigating GHK-Cu as a standalone intervention for aesthetic applications. 20 studies (18 preclinical; 2 RCTs) were included. Preclinical data consistently demonstrated that GHK-Cu enhances extracellular matrix synthesis (type I collagen and glycosaminoglycans), modulates metalloproteinase activity, and promotes angiogenesis and cellular proliferation. It also exhibited significant anti-inflammatory effects by suppressing TGF-β and IL-6. Clinically, GHK-Cu improved patient-reported satisfaction after laser resurfacing and significantly reduced wrinkle volume and depth compared with controls. Additionally, advanced delivery systems, including microneedles and liposomes, markedly improved its transdermal bioavailability and efficacy. GHK-Cu demonstrates a reasonable biological basis for use as a regenerative agent in aesthetic medicine, supported by available preclinical data. Nevertheless, the findings reported across studies were constrained by methodological variability and a limited number of well-designed clinical trials. Future research incorporating larger, controlled trials with standardized formulations, dosing regimens, and delivery methods will be necessary to close the translational gap and inform the development of consistent therapeutic protocols in clinical practice.
Mokhtar J, Mohamad B, Haddad J et al. The Regenerative Potential of GHK-Cu in Aesthetic Medicine. Aesthetic surgery journal. 2026. doi:10.1093/asj/sjag169. PMID: 42619529. https://pubmed.ncbi.nlm.nih.gov/42619529/
Related research
Home exercise may change muscle in people with kidney disease
A small trial found changes in muscle blood vessels and fewer fibrosis-linked cells after 12 weeks of home exercise. Only 25 people took part, so this does not prove the exercise caused lasting muscle benefits.
Protein NEDD4 may protect disc cells from aging and cell death in a lab test
Researchers grew disc cells in a dish with an inflammation signal. Boosting NEDD4 eased aging and cell death, and it broke down another protein called PTEN. More tests in living animals and more checks are still needed.
Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review.
Supplementation use in athletes is common and increasing in popularity, especially for adults seeking improvements in athletic performance.
Review of copper peptide GHK-Cu studies finds many lab results but few human trials
Researchers read 64 studies on GHK-Cu, a copper-linked peptide, and found much lab and animal work. They say well-designed human trials using microneedles are still needed.
A skin mix with GHK-Cu may help wrinkles and skin barrier in tests
Researchers tested a mix of a ferment extract and a copper peptide for skin aging. The results suggest it may help, but these early tests do not prove it works for everyone.
Review finds GHK-Cu promising in lab and animal studies but unproven in people
Authors reviewed studies of GHK-Cu, a copper-peptide, across labs, animals, small human tests, and drug-delivery work. They say it is not yet a proven treatment for people.
See all research on GHK-Cu (copper peptide) →